Tela Bio Stock Math Transform Exponential Price Movement
| TELA Stock | USD 0.74 -0.03 -3.90% |
| Symbol |
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Tela Bio Price Movement is a mathematical transformation function to describe exponentially increasing price patterns.
Tela Bio Technical Analysis Modules
Most technical analysis of Tela Bio help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Tela from various momentum indicators to cycle indicators. When you analyze Tela charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Stock Overview, Methodology & Data Sources
Tela Bio is scheduled to announce its earnings this week.TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patients anatomy. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania. Tela Bio operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 123 people. This overview emphasizes how Tela Bio compares to peers on valuation quality and operating consistency. Current metrics include P/B of 21.49, profit margin of -50.61%. Tela Bio has a market cap of 32.94 M, ROE of -6.76%.
Methodology
Unless otherwise specified, financial data for Tela Bio is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Tela (USA Stocks:TELA) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: The data underlying this report is sourced from public filings and market reference sources, including filings and releases published by U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Some updates may be delayed based on publication cadence. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Tela Bio may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
This content is curated and reviewed by:
Gabriel Shpitalnik - Member of Macroaxis Editorial BoardAlign your values with your investing style
Using Tela Bio inside a theme workflow gives investors a structured way to compare related stocks, funds, ETFs, and crypto assets before allocating capital. The practical benefit is that the selected idea can be tuned either for higher upside or for tighter risk control.
Thematic Opportunities
Explore Investment Opportunities
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Macroaxis Picks Invested few shares | |
 | FinTech Invested over 20 shares | |
 | Macroaxis Index Invested over 60 shares | |
 | Driverless Cars Invested few shares | |
 | Cash Cows Invested few shares | |
 | Artificial Intelligence Invested few shares | |
 | Investor Favorites Invested few shares | |
 | Disruptive Technologies Invested few shares | |
 | Impulse Invested over 200 shares | |
 | ESG Investing Invested few shares | |
 | Social Domain Invested few shares | |
 | Hedge Favorites Invested over 20 shares | |
 | Data Storage Invested few shares |
More Resources for Tela Stock Analysis
A comprehensive view of Tela Bio starts with financial statements and ratio context. Key ratios help frame profitability, efficiency, and growth context for Tela Bio Stock. Key reports that frame Tela Bio Stock are listed below:Tela Bio has a market cap of 32.94 M, operating margin of -36.51%, ROE of -6.76%. Review World Market Map for broader portfolio context. This reflects a position in Tela Bio in the portfolio view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. Our How to Invest in Tela Bio guide provides practical guidance on trading Tela Stock.Analysis related to Tela Bio should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Earnings Share -0.83 | Revenue Per Share | Quarterly Revenue Growth 0.091 | Return On Assets | Return On Equity |
Understanding Tela Bio includes distinguishing between market value and book value, where book value reflects Tela's accounting equity. Tela Bio's market capitalization is 32.94 M. With a P/B ratio of 21.49, the market values Tela Bio well above its book equity. Enterprise value stands at 45.76 M. Intrinsic value represents an estimate of underlying worth and can differ from both market price and book value. Valuation methods compare these perspectives to frame context.
It is useful to distinguish Tela Bio's value from its trading price, which are computed with different methods. For Tela Bio, key inputs include a P/B ratio of 21.49, a profit margin of -50.61%, ROE of -6.76%, and revenue of 69.3 M. By contrast, market price reflects the level where buyers and sellers transact.